Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Jun 16, 2025; 17(6): 104234
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104234
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104234
Table 3 Multivariate analysis related to rebleeding
Variables | OR | 95%CI | P value |
Age (year), mean ± SD | 1.001 | 0.950-1.054 | 0.977 |
Male sex | 0.804 | 0.153-4.216 | 0.797 |
Helicobacter pylori infection | 0.624 | 0.151-2.584 | 0.515 |
Use of anti-coagulants | 9.206 | 1.144-74.111 | 0.037a |
Use of anti-platelet | 2.243 | 0.618-8.131 | 0.219 |
Forrest classification (≥ IIa) | 1.822 | 0.499-6.655 | 0.364 |
PCAB (vs PPI) | 0.141 | 0.024-0.844 | 0.032a |
- Citation: Lim NR, Chung WC. Intravenous proton pump inhibitors vs oral potassium competitive acid blockers before endoscopic treatment of bleeding peptic ulcers. World J Gastrointest Endosc 2025; 17(6): 104234
- URL: https://www.wjgnet.com/1948-5190/full/v17/i6/104234.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i6.104234